Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 19, Issue 6, Pages R243-R253
Publisher
Bioscientifica
Online
2012-10-03
DOI
10.1530/erc-12-0232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression
- (2012) Jin-Wook Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Gender Influences the Class III and V -Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
- (2012) M. Mariani et al. CLINICAL CANCER RESEARCH
- Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer
- (2012) Kiran Mahajan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer
- (2012) Tsutomu Nishiyama JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
- (2012) Masaki Shiota et al. JOURNAL OF UROLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mono-(2-ethylhexyl) phthalate affects the steroidogenesis in rat Leydig cells through provoking ROS perturbation
- (2012) Yan Zhao et al. TOXICOLOGY IN VITRO
- Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
- (2011) Masaki Shiota et al. CURRENT CANCER DRUG TARGETS
- Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression
- (2011) M. Shiota et al. ENDOCRINE-RELATED CANCER
- A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial
- (2011) Karim Fizazi et al. EUROPEAN JOURNAL OF CANCER
- The role of oxidative stress in prostate cancer
- (2011) Gaytri Gupta-Elera et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells
- (2011) Masaki Shiota et al. FREE RADICAL BIOLOGY AND MEDICINE
- Protein sulfenic acid formation: From cellular damage to redox regulation
- (2011) Goedele Roos et al. FREE RADICAL BIOLOGY AND MEDICINE
- Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer
- (2011) Masaki Shiota et al. FREE RADICAL BIOLOGY AND MEDICINE
- Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
- (2011) Masaki Shiota et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
- (2011) James W Denham et al. LANCET ONCOLOGY
- Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
- (2011) W.-C. Huang et al. MOLECULAR CANCER RESEARCH
- SOD Mimetics: A Novel Class of Androgen Receptor Inhibitors That Suppresses Castration-Resistant Growth of Prostate Cancer
- (2011) R. Thomas et al. MOLECULAR CANCER THERAPEUTICS
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
- (2011) Christopher U. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells
- (2011) Alexandra M. Fajardo et al. PROSTATE
- Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats
- (2011) Awais Ihsan et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Beyond Castration—Defining Future Directions in the Hormonal Treatment of Prostate Cancer
- (2011) Saroj Niraula et al. Hormones & Cancer
- Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species
- (2010) Padma Sandeep Koka et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression
- (2010) Weihua Shan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells
- (2010) Jaspal Kaur Kumar et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells
- (2010) Wen-Chin Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
- (2010) Shihua Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- The Aging Stress Response
- (2010) Marcia C. Haigis et al. MOLECULAR CELL
- Androgen Receptor Counteracts Doxorubicin-Induced Cardiotoxicity in Male Mice
- (2010) Yasumasa Ikeda et al. MOLECULAR ENDOCRINOLOGY
- Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential
- (2010) Asha Acharya et al. Oxidative Medicine and Cellular Longevity
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells
- (2010) Akira Yokomizo et al. PROSTATE
- Androgen Action in Prostate Cancer
- (2010) Sujit Basu et al. Hormones & Cancer
- NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth
- (2009) Liying Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Oxidative stress-induced alternative splicing of transformer 2β (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells
- (2009) Keiko Takeo et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
- (2009) Valentina Evdokimova et al. CANCER CELL
- Oxidative stress in prostate cancer
- (2009) Lakshmipathi Khandrika et al. CANCER LETTERS
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
- (2009) M. Shiota et al. CANCER RESEARCH
- Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2–reactive oxygen species-linked signaling pathway
- (2009) Jung-A Choi et al. CARCINOGENESIS
- The Role of Androgen Receptor Mutations in Prostate Cancer Progression
- (2009) G. Brooke et al. CURRENT GENOMICS
- Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells
- (2009) Isabel Quirós et al. INTERNATIONAL JOURNAL OF CANCER
- Reactive oxygen species directly modify sodium–calcium exchanger activity in a splice variant-dependent manner
- (2009) Daniel Soliman et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression
- (2009) M Shiota et al. ONCOGENE
- BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
- (2008) R Hennig et al. BRITISH JOURNAL OF CANCER
- Twist Promotes Tumor Cell Growth through YB-1 Expression
- (2008) M. Shiota et al. CANCER RESEARCH
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
- (2008) J. A. Locke et al. CANCER RESEARCH
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Effects of Manganese Superoxide Dismutase Silencing on Androgen Receptor Function and Gene Regulation: Implications for Castration-Resistant Prostate Cancer
- (2008) N. Sharifi et al. CLINICAL CANCER RESEARCH
- Endothelin-1 enhances the expression of the androgen receptor via activation of the c-mycpathway in prostate cancer cells
- (2008) June G. Lee et al. MOLECULAR CARCINOGENESIS
- Twist and p53 reciprocally regulate target genes via direct interaction
- (2008) M Shiota et al. ONCOGENE
- Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo
- (2007) Sanjeev Pathak et al. CANCER LETTERS
- TGF-β signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells
- (2007) Meng-Lei Zhu et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now